Antibiotic resistance may be creating one of the biggest crises and opportunities, in modern medicine, and companies like BiomX (NYSE:PHGE) could be sitting at the center of the solution. Using…
Posts published in “Wall Street Wire”
As concerns over America’s fragile power grid grow, a little-known microcap, Duke Robotics (OTCQB: DUKR), is emerging as an innovative player to watch. The company’s drone technology clean and maintain…
2025 marked a turning point for Inspira Technologies (NASDAQ: IINN). The company’s FDA-cleared INSPIRA ART100 system, which delivers extracorporeal life support through advanced blood oxygenation, made the leap from concept…
As Washington prepares for what could become the most significant federal cannabis reform in half a century, InterCure (NASDAQ:INCR) is quietly positioning itself ahead of the curve. A leading GMP-certified…
While precision medicine narrows its focus, this ~$357 million company may be developing a cancer treatment that could work across many accessible solid tumor types Modern oncology is caught between…
With Big Pharma chasing injectable peptide blockbusters, Entera Bio’s tablet-based approach offers story in one of biotech’s hottest trends. When news broke that Johnson & Johnson was in talks to…
Digital health is entering a new phase, fueled by the GLP-1 revolution and employer cost pressure. With six enterprise contracts signed in October and a strategic review underway, DarioHealth sits…
With an innovative technology addressing a crucial infection-prevention challenge, PolyPid’s technology could shift hospital incentives – and its ~$50M current market cap may position it as a bargain given it’s…
After announcing a major new round of funding, DarioHealth Corp. (Nasdaq: DRIO) announced late last week that the company has initiated a comprehensive strategic review that could transform both the…
InterCure’s Newly Announced Strategic Acquisition of ISHI Comes at Historic Inflection Point as Trump Administration Explores Cannabis Rescheduling The cannabis industry is buzzing with excitement after President Trump’s drug policy…